408:
33:
182:, the term is occasionally used to describe treatments that increase (augment) the concentration of some substance in the body. This might be done when someone is deficient in a hormone, enzyme, or other endogenous substance. For example:
315:
Zhu, C; Wang, G; Li, J; Chen, L; Wang, C; Wang, Y; Lin, P; Ran, H (November 2014). "Adenosine A2A receptor antagonist istradefylline 20 versus 40 mg/day as augmentation for
Parkinson's disease: a meta-analysis".
215:
Wright, BM; Eiland EH, 3rd; Lorenz, R (March 2013). "Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature".
453:
258:
187:
272:
Begemann, MJ; Dekker, CF; van
Lunenburg, M; Sommer, IE (November 2012). "Estrogen augmentation in schizophrenia: a quantitative review of current evidence".
446:
145:
97:
477:
69:
439:
171:
116:
76:
359:
Campos, MA; Lascano, J (October 2014). "α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy".
472:
194:
54:
47:
83:
65:
149:
43:
252:
90:
415:
384:
341:
297:
240:
376:
333:
289:
232:
368:
325:
281:
224:
407:
423:
419:
466:
345:
164:
160:
388:
301:
329:
244:
179:
17:
285:
32:
133:
372:
380:
337:
293:
236:
156:
190:
in addition to L-DOPA, to reduce conversion of L-DOPA outside the brain.
144:
Prescribing an atypical antipsychotic when someone is already taking a
228:
137:
26:
427:
140:
to achieve better treatment results. Examples include:
132:, in the context of the pharmacological management of
174:
on top of existing treatment for
Parkinson's disease.
447:
8:
361:Therapeutic Advances in Respiratory Disease
257:: CS1 maint: numeric names: authors list (
136:, refers to the combination of two or more
454:
440:
117:Learn how and when to remove this message
207:
193:To give α1 antitrypsin to someone with
159:for someone already being treated with
250:
146:selective serotonin reuptake inhibitor
53:Please improve this article by adding
7:
404:
402:
25:
172:adenosine A2A receptor antagonist
406:
66:"Augmentation" pharmacology
31:
330:10.1179/1743132814y.0000000375
195:alpha 1-antitrypsin deficiency
1:
55:secondary or tertiary sources
426:. You can help Knowledge by
286:10.1016/j.schres.2012.08.016
494:
401:
478:Nervous system drug stubs
418:article relating to the
373:10.1177/1753465814542243
274:Schizophrenia Research
163:for the management of
42:relies excessively on
473:Clinical pharmacology
318:Neurological Research
148:for the treatment of
18:Augmentation agent
435:
434:
229:10.1002/phar.1204
127:
126:
119:
101:
16:(Redirected from
485:
456:
449:
442:
410:
403:
393:
392:
356:
350:
349:
312:
306:
305:
269:
263:
262:
256:
248:
212:
122:
115:
111:
108:
102:
100:
59:
35:
27:
21:
493:
492:
488:
487:
486:
484:
483:
482:
463:
462:
461:
460:
399:
397:
396:
358:
357:
353:
324:(11): 1028–34.
314:
313:
309:
280:(2–3): 179–84.
271:
270:
266:
249:
217:Pharmacotherapy
214:
213:
209:
204:
123:
112:
106:
103:
60:
58:
52:
48:primary sources
36:
23:
22:
15:
12:
11:
5:
491:
489:
481:
480:
475:
465:
464:
459:
458:
451:
444:
436:
433:
432:
420:nervous system
411:
395:
394:
351:
307:
264:
206:
205:
203:
200:
199:
198:
191:
176:
175:
168:
161:antipsychotics
153:
125:
124:
39:
37:
30:
24:
14:
13:
10:
9:
6:
4:
3:
2:
490:
479:
476:
474:
471:
470:
468:
457:
452:
450:
445:
443:
438:
437:
431:
429:
425:
421:
417:
412:
409:
405:
400:
390:
386:
382:
378:
374:
370:
367:(5): 150–61.
366:
362:
355:
352:
347:
343:
339:
335:
331:
327:
323:
319:
311:
308:
303:
299:
295:
291:
287:
283:
279:
275:
268:
265:
260:
254:
246:
242:
238:
234:
230:
226:
223:(3): 344–59.
222:
218:
211:
208:
201:
196:
192:
189:
185:
184:
183:
181:
173:
169:
166:
165:schizophrenia
162:
158:
154:
151:
147:
143:
142:
141:
139:
135:
131:
121:
118:
110:
99:
96:
92:
89:
85:
82:
78:
75:
71:
68: –
67:
63:
62:Find sources:
56:
50:
49:
45:
40:This article
38:
34:
29:
28:
19:
428:expanding it
413:
398:
364:
360:
354:
321:
317:
310:
277:
273:
267:
253:cite journal
220:
216:
210:
180:pharmacology
177:
155:Prescribing
130:Augmentation
129:
128:
113:
104:
94:
87:
80:
73:
61:
41:
107:August 2015
467:Categories
202:References
170:Giving an
150:depression
134:psychiatry
77:newspapers
44:references
346:206852879
389:32383294
381:25013223
338:24725292
302:40584474
294:22998932
237:23456734
157:estrogen
245:2421659
186:Use of
91:scholar
387:
379:
344:
336:
300:
292:
243:
235:
93:
86:
79:
72:
64:
422:is a
414:This
385:S2CID
342:S2CID
298:S2CID
241:S2CID
188:DDCIs
138:drugs
98:JSTOR
84:books
424:stub
416:drug
377:PMID
334:PMID
290:PMID
259:link
233:PMID
70:news
369:doi
326:doi
282:doi
278:141
225:doi
178:In
46:to
469::
383:.
375:.
363:.
340:.
332:.
322:36
320:.
296:.
288:.
276:.
255:}}
251:{{
239:.
231:.
221:33
219:.
57:.
455:e
448:t
441:v
430:.
391:.
371::
365:8
348:.
328::
304:.
284::
261:)
247:.
227::
197:.
167:.
152:.
120:)
114:(
109:)
105:(
95:·
88:·
81:·
74:·
51:.
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
